Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Amaral, Teresa; Schulze, Martin; Sinnberg, Tobias; Nieser, Maike; Martus, Peter; Battke, Florian; Garbe, Claus; Biskup, Saskia; Forschner, Andrea

dc.contributor.author	Amaral, Teresa
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Martus, Peter
dc.contributor.author	Garbe, Claus
dc.contributor.author	Forschner, Andrea Lydia
dc.date.accessioned	2020-09-08T12:22:35Z
dc.date.available	2020-09-08T12:22:35Z
dc.date.issued	2020
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/106430
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers12051101	de_DE
dc.subject.ddc	610	de_DE
dc.title	Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_00571
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Schulze, Martin
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Nieser, Maike
utue.personen.roh	Martus, Peter
utue.personen.roh	Battke, Florian
utue.personen.roh	Garbe, Claus
utue.personen.roh	Biskup, Saskia
utue.personen.roh	Forschner, Andrea
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	article 1101	de_DE
dcterms.isPartOf.ZS-Volume	12	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE